BlackRock’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.5M | Sell |
343,696
-146,836
| -30% | -$13.9M | ﹤0.01% | 2696 |
|
2025
Q1 | $31.1M | Buy |
490,532
+100,296
| +26% | +$6.37M | ﹤0.01% | 2636 |
|
2024
Q4 | $18.1M | Sell |
390,236
-44,502
| -10% | -$2.07M | ﹤0.01% | 3066 |
|
2024
Q3 | $12.5M | Buy |
434,738
+4,309
| +1% | +$124K | ﹤0.01% | 3248 |
|
2024
Q2 | $6.22M | Buy |
430,429
+48,712
| +13% | +$704K | ﹤0.01% | 3558 |
|
2024
Q1 | $6.14M | Buy |
381,717
+17,104
| +5% | +$275K | ﹤0.01% | 3537 |
|
2023
Q4 | $7.25M | Buy |
364,613
+28,810
| +9% | +$573K | ﹤0.01% | 3463 |
|
2023
Q3 | $5.47M | Sell |
335,803
-32,757
| -9% | -$534K | ﹤0.01% | 3566 |
|
2023
Q2 | $7.79M | Buy |
368,560
+21,334
| +6% | +$451K | ﹤0.01% | 3459 |
|
2023
Q1 | $6.97M | Buy |
347,226
+1,901
| +0.6% | +$38.2K | ﹤0.01% | 3415 |
|
2022
Q4 | $9.02M | Buy |
345,325
+345,312
| +2,656,246% | +$9.02M | ﹤0.01% | 3383 |
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 5826 |
|
2022
Q2 | $0 | Buy |
+13
| New | – | ﹤0.01% | 5864 |
|
2021
Q4 | – | Sell |
-245,594
| Closed | -$1.35M | – | 5769 |
|
2021
Q3 | $1.35M | Sell |
245,594
-4,347
| -2% | -$23.8K | ﹤0.01% | 4415 |
|
2021
Q2 | $1.64M | Buy |
+249,941
| New | +$1.64M | ﹤0.01% | 4287 |
|